Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome

被引:82
|
作者
Ding, Haigang [1 ,2 ]
Zhang, Juan [1 ,2 ]
Zhang, Feng [1 ,2 ]
Zhang, Songou [3 ]
Chen, Xiaozhen [3 ]
Liang, Wenqing [4 ]
Xie, Qiong [5 ]
机构
[1] Shaoxing Matern & Child Hlth Care Hosp, Dept Gynecol, Shaoxing, Peoples R China
[2] Shaoxing Univ, Obstet & Gynecol Hosp, Shaoxing, Peoples R China
[3] Shaoxing Univ, Coll Med, Shaoxing, Peoples R China
[4] Zhejiang Chinese Med Univ, Med Res Ctr, Zhoushan Hosp Tradit Chinese Med, Zhoushan, Peoples R China
[5] Zhejiang Chinese Med Univ, Dept Gynecol, Zhoushan Hosp Tradit Chinese Med, Zhoushan, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2021年 / 12卷
关键词
polycystic ovary syndrome (PCOS); insulin resistance; androgen; hyper-androgenemia; endocrine disorder; IMPAIRED GLUCOSE-TOLERANCE; ANTI-MULLERIAN HORMONE; METABOLIC SYNDROME; DIABETES-MELLITUS; BIOCHEMICAL HYPERANDROGENISM; ENDOCRINE PARAMETERS; PREMENOPAUSAL WOMEN; MOLECULAR DEFECTS; CONCEPTION RATES; FOLLICULAR-FLUID;
D O I
10.3389/fendo.2021.741764
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PCOS has a wide range of negative impacts on women's health and is one of the most frequent reproductive systemic endocrine disorders. PCOS has complex characteristics and symptom heterogeneity due to the several pathways that are involved in the infection and the absence of a comm14on cause. A recent study has shown that the main etiology and endocrine aspects of PCOS are the increased level of androgen, which is also known as "hyperandrogenemia (HA)" and secondly the "insulin resistance (IR)". The major underlying cause of the polycystic ovary is these two IR and HA, by initiating the disease and its severity or duration. As a consequence, study on Pathogenesis is crucial to understand the effect of "HA" and "IR" on the pathophysiology of numerous symptoms linked to PCOS. A deep understanding of the pattern of the growth in PCOS for HA and IR can help ameliorate the condition, along with adjustments in nutrition and life, as well as the discovery of new medicinal products. However, further research is required to clarify the mutual role of IR and HA on PCOS development.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Insulin Resistance and Polycystic Ovary Syndrome
    Moghetti, Paolo
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (36) : 5526 - 5534
  • [2] Study of androgen and androgen receptor in relation to insulin resistance in polycystic ovary syndrome
    Chu Yongli
    Sun Yongyu
    Qiu Hongyu
    Current Medical Science, 2003, 23 (1) : 52 - 54
  • [3] Insulin resistance in polycystic ovary syndrome
    Schröder, AK
    Tauchert, S
    Ortmann, O
    Diedrich, K
    Weiss, JM
    WIENER KLINISCHE WOCHENSCHRIFT, 2003, 115 (23) : 812 - 821
  • [4] Study of Androgen and Androgen Receptor in Relation to Insulin Resistance in Polycystic Ovary Syndrome
    初永丽
    孙永玉
    邱红玉
    华中科技大学学报(医学英德文版), 2003, (01) : 52 - 54
  • [5] Polycystic Ovary Syndrome, Insulin Resistance, and Cardiovascular Disease
    Dubey, Pallavi
    Reddy, Sireesha
    Sharma, Kunal
    Johnson, Sarah
    Hardy, Ghislain
    Dwivedi, Alok Kumar
    CURRENT CARDIOLOGY REPORTS, 2024, 26 (06) : 483 - 495
  • [6] Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome
    Hong, So-hyeon
    Sung, Yeon-Ah
    Hong, Young Sun
    Jeong, Kyungah
    Chung, Hyewon
    Lee, Hyejin
    CLINICAL ENDOCRINOLOGY, 2017, 87 (04) : 375 - 380
  • [7] Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome
    Wang, Juan
    Wu, Daichao
    Guo, Hui
    Li, Meixiang
    LIFE SCIENCES, 2019, 236
  • [8] Polycystic Ovary Syndrome and Insulin Resistance
    Mendoza, Nicolas
    JOURNAL OF DIABETES & METABOLISM, 2012, 4
  • [9] Insulin Resistance and Polycystic Ovary Syndrome Through Life
    Diamanti-Kandarakis, Evanthia
    Spritzer, Poli Mara
    Sir-Petermann, Teresa
    Beatriz Motta, Alicia
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (34) : 5569 - 5576
  • [10] Insulin resistance in patients with polycystic ovary syndrome is associated with elevated plasma homocysteine
    Schachter, M
    Raziel, A
    Friedler, S
    Strassburger, D
    Bern, O
    Ron-El, R
    HUMAN REPRODUCTION, 2003, 18 (04) : 721 - 727